Cellebrite DI Ltd. CLBT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -32.61%
- 1 year
- -29.24%
- Open
- 12.24
- Prev close
- 12.28
- Mkt cap
- 3.05B
- Vol
- 1.52M
- Avg vol
- 3.03M
- EPS
- 0.23
- P/E
- 52.83
- Div yield
- 0.00%
More statistics
- Low
- 12.02
- High
- 12.27
- Forward P/E
- 18.60
- Beta
- 1.13
- Short ratio
- 2.90
- Inst. own
- 53.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 11.48
- 200-d avg
- 13.43
- 1y target
- 15.36
News
1 week ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
1 week ago prnewswire.com
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
Investigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.
1 week ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised…
1 week ago prnewswire.com
Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
1 week ago prnewswire.com
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Oct. 20, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the…
1 week ago defenseworld.net
Cellebrite DI (NASDAQ:CLBT) CFO David Barter Sells 12,134 Shares of Company Stock
Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) CFO David Barter sold 12,134 shares of Cellebrite DI stock in a transaction that occurred on Friday, October 16th. The shares were sold at an…
2 weeks ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
2 weeks ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised…
3 weeks ago newsfilecorp.com
Kaplan Fox Shareholder Alert: Cellebrite DI Ltd. (CLBT) is Under Investigation for Possible Securities Law Violations
New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
3 weeks ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
3 weeks ago newsfilecorp.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses
New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
3 weeks ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised…
1 month ago newsfilecorp.com
CLBT INVESTIGATION: Cellebrite Investigated by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses
Boston, Massachusetts--(Newsfile Corp. - October 2, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in…
1 month ago newsfilecorp.com
Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm
New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
1 month ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
1 month ago newsfilecorp.com
Kaplan Fox Reminds Investors of Cellebrite DI Ltd. (CLBT) of an Ongoing Securities Investigation
New York, New York--(Newsfile Corp. - September 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
1 month ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised…
1 month ago fool.com
Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound
Cellebrite maintains a strong competitive moat through deep integration with government and law enforcement. Recent guidance resets and CEO turnover highlight execution risks for the software pivot.
1 month ago newsfilecorp.com
Kaplan Fox Is Investigating Cellebrite DI Ltd. (CLBT) on Behalf of Shareholders for Possible Securities Law Violations
New York, New York--(Newsfile Corp. - September 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
1 month ago newsfilecorp.com
Kaplan Fox Advises Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company")…
-
2 months ago benzinga.com
Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.
-
2 months ago benzinga.com
JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.
-
2 months ago benzinga.com
DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.
-
2 months ago benzinga.com
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $15 to $12.5.
2 months ago benzinga.com
12 Information Technology Stocks Moving In Thursday's Intraday Session
Gainers BGIN Blockchain (NASDAQ:BGIN) stock rose 38.8% to $2.36 during Thursday's regular session. The company's market cap stands at $192.3 million. Iveda Solutions (NASDAQ:IVDA) shares moved…
2 months ago benzinga.com
Cellebrite Shares Plunge Thursday: What's Driving the Move?
Shares of Cellebrite are trading sharply lower on Thursday following the release of second-quarter financial results that missed top-line expectations alongside downgraded revenue guidance for the…
2 months ago benzinga.com
Gold Down 2%; Cisco Shares Tumble After Q4 Results
US stocks mixed, Nasdaq up more than 150 points. Dow down 0.16% to 53,682.87, Nasdaq up 0.61% to 26,749.51, S&P 500 up 0.45% to 7,783.09. Real estate sector up 1.2%, energy down 1%. Cisco shares down…
2 months ago benzinga.com
Full Transcript: Cellebrite DI Q2 2026 Earnings Call
Cellebrite DI (NASDAQ:CLBT) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought…
2 months ago benzinga.com
Dow Gains Over 100 Points; Producer Prices Unchanged In July
US stocks up, Dow gains over 100 points. Real estate sector rises, energy sector falls. Producer Price Index unchanged, inflation rate down.
2 months ago benzinga.com
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Gainers Yxt.Com Group Holding (NASDAQ:YXT) stock moved upwards by 47.5% to $6.68 during Thursday's pre-market session. The company's market cap stands at $27.6 million. As per the press release, H1…
-
2 months ago benzinga.com
Cellebrite DI Lowers FY2026 Sales Guidance from $565.000M-$571.000M to $555.000M-$561.000M vs $568.048M Est
Cellebrite DI (NASDAQ:CLBT) lowers FY2026 sales outlook from $565.000 million-$571.000 million to $555.000 million-$561.000 million vs $568.048 million estimate.
-
2 months ago benzinga.com
Cellebrite DI Sees Q3 Sales $145.000M-$148.000M vs $150.298M Est
Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $145.000 million-$148.000 million vs $150.298 million analyst estimate.
-
2 months ago benzinga.com
Cellebrite DI Q2 Adj. EPS $0.11, Inline, Sales $131.138M Miss $131.874M Estimate
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.11 per share which met the analyst consensus estimate. This is a 8.33 percent decrease over earnings of $0.12 per share from the same…
-
2 months ago benzinga.com
DA Davidson Maintains Buy on Cellebrite DI, Raises Price Target to $22
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.
-
5 months ago benzinga.com
DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20
DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.
-
5 months ago benzinga.com
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $15
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $18 to $15.
-
5 months ago benzinga.com
Cellebrite DI Q1 2026 Earnings Call Transcript
Cellebrite DI Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
Cellebrite Announces FedRAMP High Authorization For Its Cellebrite Government Cloud Platform
Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that its Cellebrite Government…
-
6 months ago benzinga.com
12 Information Technology Stocks Moving In Friday's After-Market Session
12 Information Technology Stocks Moving In Friday's After-Market Session
-
8 months ago benzinga.com
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $18
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $18.
-
8 months ago benzinga.com
Cellebrite DI Sees FY2026 Sales $565.000M-$571.000M vs $554.864M Est
Cellebrite DI (NASDAQ:CLBT) sees FY2026 sales of $565.000 million-$571.000 million vs $554.864 million analyst estimate.
-
8 months ago benzinga.com
Cellebrite DI Sees Q1 Sales $126.000M-$128.000M vs $130.637M Est
Cellebrite DI (NASDAQ:CLBT) sees Q1 sales of $126.000 million-$128.000 million vs $130.637 million analyst estimate.
-
8 months ago benzinga.com
Cellebrite DI Q4 Adj. EPS $0.14, Inline, Sales $128.821M Beat $126.556M Estimate
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 40 percent increase over earnings of $0.10 per share from the same…
-
8 months ago benzinga.com
Earnings Scheduled For February 11, 2026
Earnings Scheduled For February 11, 2026
10 months ago benzinga.com
Security Tech Check-In: Analyst Insights From 12 Companies Ahead Of The 'Quiet Period'
Needham analysts met with 12 companies before quiet period. Ratings and price targets by analyst Mike Cikos.
11 months ago benzinga.com
These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week
These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week
-
11 months ago benzinga.com
JP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $24
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $23 to $24.
-
11 months ago benzinga.com
Lake Street Maintains Buy on Cellebrite DI, Raises Price Target to $23
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $22 to $23.